Los Angeles Times: Peter Whitehouse, professor at the College of Arts and Sciences, said drug trial investigators can “earn phenomenal amounts” for the patients they recruit. “There’s a bias for them to want to get people into these studies,” he said, noting that in some cases, he has found, “they overpromise the likely results of these trials and create false hope.”

College of Arts and Sciences' Peter Whitehouse discusses Alzheimer drug trials in California
MEDIA |
July 25, 2023
STORY BY: EDITORIAL STAFF
STORY BY: EDITORIAL STAFF